XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net Revenues    
Total Revenues, net $ 18,198,112 $ 4,304,812
Cost of revenues 3,263,253 1,337,650
Gross Profit 14,934,859 2,967,162
Expenses    
Selling & marketing expenses 18,640,731 2,745,882
General and administrative expenses 6,863,879 1,590,967
Other operating expenses 861,081 124,491
Customer service expenses 295,277 168,185
Development Costs 192,228 78,142
Total expenses 26,853,196 4,707,667
Operating Loss (11,918,337) (1,740,505)
Other Income (Expenses)    
Interest expense, net (139,463) (793,039)
Gain on debt forgiveness 184,914
Total 45,451 (793,039)
Net Loss before provision for income taxes (11,872,886) (2,533,544)
Provision for income taxes
Net Loss (11,872,886) (2,533,544)
Net (loss) attributable to noncontrolling interests (270,503) (138,816)
Net loss attributable to LifeMD, Inc. common stockholders $ (11,602,383) $ (2,394,728)
Basic loss per share attributable to LifeMD, Inc. common stockholders $ (0.47) $ (0.23)
Diluted loss per share attributable to LifeMD, Inc. common stockholders $ (0.47) $ (0.23)
Weighted Average number of common shares outstanding:    
Basic 24,467,788 10,697,767
Diluted 24,467,788 10,697,767
Product Revenues, Net [Member]    
Net Revenues    
Total Revenues, net $ 13,283,315 $ 2,955,801
Cost of revenues 3,123,025 1,252,747
Software Revenues, Net [Member]    
Net Revenues    
Total Revenues, net 4,914,797 1,349,011
Cost of revenues 140,228 84,903
Service Revenues, Net [Member]    
Net Revenues    
Total Revenues, net